Page last updated: 2024-10-31

entinostat and Astrocytoma, Grade IV

entinostat has been researched along with Astrocytoma, Grade IV in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Glioblastoma is the most common primary brain tumor with a dismal prognosis, highlighting the need for novel treatment strategies."1.37Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275. ( Bangert, A; Cristofanon, S; Debatin, KM; Fulda, S; Häcker, S, 2011)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Lu, Y1
Feng, Y1
Li, Z1
Li, J1
Zhang, H1
Hu, X1
Jiang, W1
Shi, T1
Wang, Z1
Sun, P1
Xia, S1
Lal, B1
Eberhart, CG1
Quinones-Hinojosa, A1
Maciaczyk, J1
Matsui, W1
Dimeco, F1
Piccirillo, SM1
Vescovi, AL1
Laterra, J1
Bangert, A1
Häcker, S1
Cristofanon, S1
Debatin, KM1
Fulda, S1
Bagci-Onder, T1
Agarwal, A1
Flusberg, D1
Wanningen, S1
Sorger, P1
Shah, K1

Other Studies

4 other studies available for entinostat and Astrocytoma, Grade IV

ArticleYear
Novel piperazine based benzamide derivatives as potential anti-glioblastoma agents inhibiting cell proliferation and cell cycle progression.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Animals; Antineoplastic Agents; Benzamides; Cell Cycle; Cell Proliferation; Dose-Response Relationsh

2022
DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.
    Stem cells (Dayton, Ohio), 2009, Volume: 27, Issue:7

    Topics: Animals; Benzamides; Brain Neoplasms; Cell Differentiation; Cell Line, Tumor; Electrophoresis, Polya

2009
Chemosensitization of glioblastoma cells by the histone deacetylase inhibitor MS275.
    Anti-cancer drugs, 2011, Volume: 22, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplasti

2011
Real-time imaging of the dynamics of death receptors and therapeutics that overcome TRAIL resistance in tumors.
    Oncogene, 2013, Jun-06, Volume: 32, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cell Survival; Coculture Techniques; Drug Res

2013